Revival of anti-angiogenic therapies in cancer—news on an old therapeutic concept
Sign Up to like & getrecommendations! Published in 2017 at "memo - Magazine of European Medical Oncology"
DOI: 10.1007/s12254-017-0363-z
Abstract: Inhibition of angiogenesis became clinical reality in 2004 with the approval of bevacizumab in metastatic colorectal cancer and we are now approaching the expiration dates of the patents for bevacizumab in the US in July… read more here.
Keywords: concept; angiogenic therapies; cancer entities; cancer ... See more keywords